Clinical Trials Directory

Trials / Completed

CompletedNCT01237080

Intubation of Morbidly Obese Patients. A Clinical Trial, Comparing Glide Scope ® With Fastrach TM

Intubation of Morbidly Obese Patients. A Randomized Clinical Trial, Comparing GlideScope ® With Fastrach TM.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Glostrup University Hospital, Copenhagen · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare the GlideScope ® and the Fastrach TM for intubation of morbidly obese. Mainly we will try to clarify which of the instruments that produce the shortest intubationtime and lowest number of intubationattempts. The hypothesis is that intubation would be 1) quicker and 2) with the lowest number of attempts, using the GlideScope®.

Detailed description

The number of obese people rises. Thus 25.2% of Danish 9th graders are obese. As a result, surgery and anesthesia in obese patients becomes more frequent. Several potential problems related to anesthesia in this patient group exists, including airway management and sufficient oxygenation. Anaesthesia of obese patients are more likely to require intubation. In light of the foregoing, it is therefore important to find the methods that provide the fewest complications related to intubation. Therefore this study compare two instruments (Fastrach TM and GlideScope ®) to find out which of the methods that provides the best airway management, measured primarily in time and numbers of intubation attempts.

Conditions

Interventions

TypeNameDescription
DEVICEGlideScopeThe GlideScope is an anatomically shaped, rigid, fibreoptic videolaryngoscope.
DEVICEFastrachThe Fastrach is an intubation laryngeal mask.

Timeline

Start date
2010-09-01
Primary completion
2011-01-01
Completion
2011-01-01
First posted
2010-11-09
Last updated
2013-02-20
Results posted
2013-02-20

Locations

2 sites across 1 country: Denmark

Source: ClinicalTrials.gov record NCT01237080. Inclusion in this directory is not an endorsement.